The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:21 - 55
Updated:2/10/2018
Start Date:April 2007
End Date:October 2016

Use our guide to learn which trials are right for you!

The purpose of this study is to examine how smoking cessation medications (varenicline,
bupropion) affect the ability to resist smoking and also subsequent ad-lib smoking in
non-treatment seeking daily smokers.


Inclusion Criteria:

- ages 18-55

- able to read and write in English

- Smokers

Exclusion Criteria:

- any significant current medical or psychiatric conditions that would contraindicate
smoking

- current Diagnostic and Statistical Manual IV abuse or dependence of other substances,
other than nicotine dependence or alcohol abuse

- positive test result at intake appointments on urine drug screens conducted for
opiates, cocaine, or benzodiazepines

- women who are pregnant or nursing

- suicidal, homicidal, or evidence of current severe mental illness

- participants prescribed any psychotropic drug in the 30 days prior to study enrollment

- blood donation within the past 6 weeks

- individuals seeking treatment for smoking cessation or have attempted to quit smoking
within the past 3 months

- specific exclusions for bupropion administration not already specified, including:
have taken monoamine inhibitors in the past 6 weeks; history of anorexia or bulimia;
previous hypersensitivity to bupropion; history of alcohol or drug dependence in the
past year; history of seizure disorder of any etiology

- known allergy to varenicline or taking H2blockers

- participation within the past 8 weeks in other studies that involve additive blood
sampling and/or interventional measures that would be considered excessive in
combination with the current study
We found this trial at
1
site
?
mi
from
New Haven, CT
Click here to add this to my saved trials